Cause of Death and Survival After Complications in Type 1 Diabetes - Bosnyak, Zsolt
22,99 €
inkl. MwSt.

Versandfertig in über 4 Wochen
  • Broschiertes Buch

Despite the major increase in life expectancy and the development of new technology in diabetes health care, individuals who develop Type 1 diabetes remain at substantially greater risk of early mortality. The acute and chronic complications of diabetes might markedly contribute to this. However, little is known about the underlying cause of this mortality excess, gender and national/ethnic differences and the temporal changes in mortality by the different diabetes complications. Once complication developed, survival pattern becomes important in order to find better approaches to prolong…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Despite the major increase in life expectancy and the development of new technology in diabetes health care, individuals who develop Type 1 diabetes remain at substantially greater risk of early mortality. The acute and chronic complications of diabetes might markedly contribute to this. However, little is known about the underlying cause of this mortality excess, gender and national/ethnic differences and the temporal changes in mortality by the different diabetes complications. Once complication developed, survival pattern becomes important in order to find better approaches to prolong lifetime. This work has been dedicated to evaluate the cause specific mortality pattern of Type 1 diabetes in countries with different health care systems (USA and Cuba) and people with different ethnic background. The presence and effect of major diabetes complications (coronary artery disease and renal disease) were also investigated along with demographic factors and causes influencing survival, also after invasive treatment.
Autorenporträt
The author holds nearly 20 years of diabetes clinical practice and research experience. He was involved in large-scale international prospective studies in type 1 diabetes mortality and complications and completed his PhD in 2009. He is a board certified internist and diabetes specialist currently acting in various innovative health-care roles.